Consultant at the Boston Consulting Group – BCG
Dr. Ryan Goosen holds a Ph.D. in Medical Biochemistry from the University of Cape Town. His prior Bachelor’s degrees had Computer Science and Biochemistry as majors and Bioinformatics as a specialization. Ryan joined BCG in 2016 and focuses on the intersection of Healthcare and Technology. In particular, his expertise spans topics within competitive strategy, Digital Health, and Cybersecurity. He typically works with clients in the Pharmaceutical industry. Prior to joining BCG, Ryan worked within the Healthcare and Information Technology sector. His prior roles focused on bioinformatics, software engineering, IT consulting, and founding technology-driven start-ups.
Editorial Director of the F1000 platform, an open research publishing platform for life scientists
Dr. Sabina Alam is Editorial Director of the F1000 Platform, an open research publishing platform for life scientists that offers immediate publication of articles with an open peer review and revision process. She holds a Ph.D. degree in Neuroimmunology from the University of Bath and was a postdoctoral researcher in Neuroscience at the School of Pharmacy at the University of London, where she did research on the signaling and trafficking mechanisms of inhibitory neurotransmitter receptors. In 2008 she joined Biomed Central as an Assistant Editor on the the BMC Series, a collection of journals covering biology and medicine. She became the Editor of BMC Medicine in 2011, and in 2017 joined the F1000 Platform as an Editorial Director.
Maria Grazia Giuffreda
Associate Director & Head of User Engagement and Support at Swiss National Supercomputing Center – CSCS
Dr. Maria-Grazia Giuffreda is currently working for the Swiss National Supercomputing Centre, a centre that develops and provides key supercomputing capabilities required to solve important problems to science and/or society. They enable world-class research with a scientific user lab that is available to domestic and international researchers through a transparent, peer-reviewed allocation process. She holds a PhD in computational chemistry, did a 4-year postdoc at ETH Zurich and joined CSCS in 2006.
Wolfgang Moritz, InSphero
Cell-based Assays to Detect Cell Health in Real-Time and the Mechanism Of Toxicity
Dr. Wolfgang Moritz is Head of Research and Applications at InSphero, responsible for early stage product development and related applications. He holds a Ph.D. degree in Biochemistry from the University of Zurich and spent 4 years as a postdoctoral fellow at the Massachusetts General Hospital in Boston where he was involved in Diabetes related research. Back in Switzerland he led a research group at the University Hospital of Zurich focused on pancreatic islet transplantation and later on in the surgical department, overseeing several projects interrelated to the diseased liver. He was also appointed as technical director of the HLA tissue typing laboratory of the University Hospital in Zurich. In 2009 Wolfgang Moritz co-founded InSphero, a company dedicated to the development and commercialization of standardized and highly functional organotypic microtissues amenable for disease modelling as well as for efficacy and safety testing for the pharmaceutical, chemical and cosmetics industry.